Liuliumei Co., Ltd. (Ticker: 6658 HK) is a Chinese packaged food company specializing in green plum-based and related food products. The company manufactures green plum wines, pulps, jellies, cakes, dried fruits, dried vegetables, condiments and other food products, and also conducts import and export business.

Liuliumei plans to list on the Hong Kong Stock Exchange on June 15, 2026. According to published terms, the company priced its IPO at HKD 43.58 per share, offering 11.46 million primary shares and raising approximately HKD 500 million, or about USD 64 million. The IPO implies a market capitalization at offer of approximately USD 438 million.

The offering consists entirely of primary shares, with a 15% greenshoe facility of approximately 1.72 million shares. The IPO managers include CEB International Capital, CITIC Securities, Guoyuan Securities Brokerage Hong Kong, Huafu International Securities, Orient Securities Hong Kong and Soochow Securities.

GO Inc. (Ticker: 581A JP) is a Japanese company providing mobility-related services, including taxi dispatch systems and other technology services for the mobility industry. The company is domiciled in Japan and operates the taxi app “GO,” while also developing businesses related to traffic safety, decarbonization, driver shortages and local community mobility.

GO plans to list on the Tokyo Stock Exchange Growth Market on June 16, 2026. According to published terms, the IPO consists entirely of a secondary sale of 36.9 million shares, with no newly issued shares, at an indicated price range of ¥2,350 to ¥2,400 per share. At the ¥2,375 midpoint, the offering would raise approximately ¥87.7 billion, or about $548 million. The estimated market capitalization is around $1.2 billion.

GO reported consolidated revenue of approximately ¥31.4 billion and net income of about ¥2.0 billion for the fiscal year ended May 2025. For the fiscal year ending May 2026, the company forecasts revenue of ¥40.8 billion and net income of ¥6.4 billion. Nomura Securities is listed as lead manager.

Bohus ASA (Ticker: BOHUS NO) is a Norwegian retail group operating in the furniture and home furnishings market. Founded in 1976, Bohus operates an omnichannel platform with 72 stores across Norway, including 66 fully owned stores and six franchise stores, supported by a central warehouse of more than 30,000 square meters and an online channel.

Bohus plans to list on Euronext Oslo Børs on or about 16-18 June 2026. According to published terms, the IPO comprises up to 30.0 million existing shares offered by selling shareholders at NOK 31.00 per share, raising approximately NOK 930 million, or about $98 million. If the 14% greenshoe option is fully utilized, the offering will increase to 34.2 million shares and approximately NOK 1.06 billion. The offer price implies a pre-money equity value of NOK 3.03 billion, or around $320 million. ABG Sundal Collier, DNB Carnegie and SEB are acting as managers.

SENASIC Electronics Technology Co., Ltd. (Ticker: 6675 HK) is a Chinese semiconductor company developing, manufacturing and selling sensor chips and related semiconductor products. The company focuses on wireless sensor SoCs, including automotive-grade wireless sensor SoCs, and also produces semiconductor integrated circuits, membrane integrated circuits, automotive integrated circuit chips and medical electronic chips.

SENASIC plans to list H shares on the Hong Kong Stock Exchange Main Board on June 17, 2026. According to published terms, the company plans to offer 53.41 million primary shares at HKD 18.36 per share, raising approximately HKD 981 million, or about USD 125 million. The IPO implies a market capitalization at offer of approximately USD 888 million.

According to the prospectus summary, SENASIC was the third-largest automotive wireless sensor SoC company globally and the largest in China by revenue in 2025. The company plans to use the IPO proceeds for R&D and product capacity, brand promotion and business development, working capital and strategic acquisitions. The offering includes a 15% greenshoe facility of approximately 8.01 million shares.

Kardigan, Inc. (Ticker: KARD US) is an American late-stage biotechnology company incorporated in Delaware and focused on precision cardiovascular therapies. The company is advancing three clinical programs: danicamtiv for genetic dilated cardiomyopathy, ataciguat for calcific aortic valve stenosis, and tonlamarsen for acute severe hypertension post-hospitalization. Kardigan also operates Prolaio, a proprietary data and analytics platform using wearable sensors and AI-driven analytics to support clinical trials and digital clinical endpoints.

Kardigan plans to list on the NASDAQ on June 18, 2026. According to published terms, the company plans to offer 23.33 million shares at a price range of $14.00 to $16.00 per share, raising approximately $350 million at the midpoint. The estimated market capitalization is approximately $1.3 billion.

For the 12 months ended March 31, 2026, Kardigan reported no product revenue and a net loss of approximately $230 million. The company was founded in 2023 and had 241 employees. J.P. Morgan, Jefferies, Leerink Partners and TD Cowen are serving as joint bookrunners.

First Carolina Financial Services, Inc. (Ticker: FCBM US) is an American community bank holding company headquartered in Raleigh, North Carolina, and incorporated in the United States. Its flagship subsidiary, First Carolina Bank, provides consumer and commercial banking services to individuals, professionals, small and medium-sized businesses, and higher-education institutions across North Carolina, South Carolina, Georgia and Virginia.

First Carolina Financial Services plans to list on the NYSE on June 18, 2026. According to published terms, the company plans to offer 5.5 million shares at a price range of $14.00 to $16.00 per share, raising approximately $83 million at the midpoint. The estimated market capitalization is approximately $452 million. Keefe, Bruyette & Woods is serving as sole bookrunner.

Shenzhen HQVT Technology Co., Ltd. (Ticker: 1392 HK) is a Chinese multispectral AI technology company specializing in the acquisition, processing and analysis of optical information across multiple spectrum bands. The company offers multispectral AI modules, AI perception terminals and multispectral AI large model services, including its proprietary “Zhiyuan Origin Large Model,” serving customers in software, information technology, electronics, telecommunications, intelligent driving, IoT, smart city and safety-monitoring applications.

HQVT Technology plans to list on the Hong Kong Stock Exchange Main Board on June 22, 2026. According to published terms, the company plans to offer 85.16 million primary shares at HKD 7.20 per share, raising approximately HKD 613 million, or about USD 78 million. The IPO implies a market capitalization at offer of approximately USD 695 million.

According to the prospectus summary, HQVT Technology was established in 2013 and had registered 101 invention patents and 46 software copyrights as of the latest practicable date. The company plans to use the IPO proceeds for R&D and product capacity, brand promotion and business development, working capital and strategic acquisitions.

Shenzhen Senior Technology Material Co., Ltd. (Ticker: 6067 HK) is a Chinese specialty chemicals and battery materials company that designs, manufactures and sells lithium-ion battery separators, including dry process, wet process and coated separators, as well as ceramic and polymer coating products. The company serves lithium-ion battery manufacturers globally and was founded in 2003.

Shenzhen Senior Technology Material plans to list H shares on the Hong Kong Stock Exchange Main Board on June 23, 2026. According to published terms, the company plans to offer 149.52 million primary shares at an expected price of HKD 8.98 per share, raising approximately HKD 1.34 billion, or about USD 171 million.

According to the prospectus summary, the company ranked second globally by lithium-ion battery separator shipment volume for the last six consecutive years, with an 11.6% global market share in 2025. It also ranked second in the Chinese Mainland battery separator market in 2025. The company has five manufacturing bases in China, overseas manufacturing bases under construction in Europe, Southeast Asia and the U.S., and R&D centres in China, Japan and Sweden.

HJ Science Co., Ltd. (Ticker: 6132 HK) is a Chinese biotechnology company developing new medicines for immune system disorders, metabolic conditions and cancer. Founded in 2017, the company is still in the clinical-stage, meaning its main drug candidates are being tested and have not yet reached broad commercial launch.

HJ Science’s three main drug candidates target conditions including skin inflammation diseases such as atopic dermatitis and psoriasis, type 2 diabetes and potential weight-management uses, and a form of lung cancer linked to a specific genetic mutation.

HJ Science plans to list H shares on the Hong Kong Stock Exchange Main Board on June 23, 2026. According to published terms, the company priced its IPO at HKD 81.80 per share, offering 13.60 million primary shares and raising approximately HKD 1.11 billion, or about USD 142 million. The IPO implies a market capitalization at offer of approximately USD 768 million.

According to the prospectus summary, IPO proceeds will be used for R&D and product capacity, brand promotion and business development, working capital and strategic acquisitions.

STRADVISION, Inc. (Ticker: 475040 KS) is a South Korean applied software development company specializing in AI-based vision perception software for automotive applications. Its flagship SVNet platform processes camera data in real time to detect road objects such as vehicles, pedestrians and lane markings, supporting ADAS and autonomous driving systems. The company also operates SVDataFlow, an integrated data pipeline for automated data processing and model development.

STRADVISION plans to list on KOSDAQ on June 30, 2026. According to published terms, the company plans to offer 7.0 million newly issued shares at an indicative price range of KRW 12,000 to KRW 14,000 per share, raising approximately KRW 84 billion at the low end, or about $57 million. KB Securities is serving as lead underwriter.

Founded in 2014, STRADVISION has surpassed 5 million cumulative vehicle deployments worldwide through partnerships with global automotive OEMs and has secured more than 1,000 patents globally. For 2025, the company reported revenue of KRW 11.5 billion and a net loss of KRW 65.5 billion. Aptiv Technologies AG is the largest shareholder, with a 42% stake.